In vivo mesenchymal stem cell tracking with PET using the dopamine type 2 receptor and 18F-fallypride.
Schönitzer V, Haasters F, Käsbauer S, Ulrich V, Mille E, Gildehaus FJ, Carlsen J, Pape M, Beck R, Delker A, Böning G, Mutschler W, Böcker W, Schieker M, Bartenstein P.
Schönitzer V, et al. Among authors: gildehaus fj.
J Nucl Med. 2014 Aug;55(8):1342-7. doi: 10.2967/jnumed.113.134775. Epub 2014 Jul 14.
J Nucl Med. 2014.
PMID: 25024426
Free article.